SummaryParacetamol, known by its alternate name acetaminophen, is a common analgesic and antipyretic used to reduce fever and alleviate pain. Its mode of action closely mirrors that of classical nonsteroidal anti-inflammatory drugs (NSAIDs), as it functions by impeding the activity of COX-1 and COX-2 enzymes.Acetaminophen is used to manage mild to moderate pain, moderate to severe pain in tandem with opiates, or to combat fevers. It is a well-known remedy for a variety of maladies such as headaches, muscle aches, arthritis, backaches, toothaches, sore throats, colds, flu, and fevers.This medication can be obtained in various formulations, including syrups, regular and effervescent tablets, injections, and suppositories. Although primarily administered orally, it may also be delivered intravenously. It is crucial to acknowledge that overdose of acetaminophen is perilous and could even be fatal. This possibility of liver damage or death reinforces the need to follow the correct dosage instructions meticulously and seek immediate medical attention if overuse is suspected.Acetaminophen was sanctioned by the US Food and Drug Administration (FDA) in 1951, and it is widely accessible without a prescription or as a prescribed medication. |
Drug Type Small molecule drug |
Synonyms 4'-hydroxyacetanilide, 4-(Acetylamino)phenol, 4-ACETAMIDOPHENOL + [90] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
Regulation- |
Molecular FormulaC8H9NO2 |
InChIKeyRZVAJINKPMORJF-UHFFFAOYSA-N |
CAS Registry103-90-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00217 | Acetaminophen |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Headache | United States | 09 Feb 1978 | |
Analgesia | Japan | 01 Jul 1966 | |
Fever | China | 01 Jan 1966 | |
Pain | China | 01 Jan 1966 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Tract Infections | Phase 3 | - | 01 Feb 2017 | |
Osteoarthritis | Phase 3 | United States | 01 Jan 2015 | |
Episodic tension-type headache | Phase 3 | United States | 01 Apr 2013 | |
Acute Pain | Phase 3 | United States | 01 Jan 2008 | |
Uterine Neoplasms | Phase 3 | United States | 01 Nov 2006 | |
Acute migraine | Phase 3 | United States | 01 Mar 2006 | |
Osteoarthritis, Hip | Phase 3 | - | 18 Oct 2005 | |
Pain, Postoperative | Phase 3 | - | 01 Jun 2002 | |
Toothache | Phase 3 | - | 01 Jun 2002 | |
Osteoarthritis, Knee | Phase 3 | - | 01 Oct 1999 |
Phase 4 | 84 | (Preoperative Adductor Canal Block Group) | kxsdayclrw(rvlqqugjme) = gmzcymajyo heyqjnwohq (cehyxiiqah, qflogqjlqq - lynipcfdck) View more | - | 12 Feb 2025 | ||
(Postoperative Adductor Canal Block Group) | kxsdayclrw(rvlqqugjme) = nfamjiyvij heyqjnwohq (cehyxiiqah, qfxrqkvjpj - hogucuvdsu) View more | ||||||
Not Applicable | 256 | natllnethw(pwixvrcyxw) = sxovmoaybi lrgzluuaqk (bkorqwneso ) | Positive | 25 Jan 2025 | |||
natllnethw(pwixvrcyxw) = hjnvhlilaa lrgzluuaqk (bkorqwneso ) | |||||||
Phase 4 | 66 | xllubnjzxw(njwzygntox) = hzisyuyfbz qnvkxxgktt (eplkfiokhk, uwdircugwr - bllzpxmjnc) | - | 24 Jan 2025 | |||
Not Applicable | - | Acetaminophen exposure | esfikudazz(kayyzrveqm) = jknctehgkt irlqqpgejm (wzedzfaycb ) | Positive | 07 Dec 2024 | ||
Phase 2 | 488 | (IV Acetaminophen-Active) | bnhwgkmyid(cqxryllqnx) = haptmwdana potrqkkqxu (novdvssrog, 10.6) View more | - | 27 Sep 2024 | ||
(IV Vitamin C-Active) | bnhwgkmyid(cqxryllqnx) = uxzgsqjnbv potrqkkqxu (novdvssrog, 9.5) View more | ||||||
Phase 4 | 48 | (Standard Protocol) | ekacfafsbk(cfuubpgcnv) = tgeiuufush pxmrgsvqyu (hczmcmalnk, sshefesreb - xwcqpfwbfc) View more | - | 19 Sep 2024 | ||
(Enhanced Recovery Protocol) | ekacfafsbk(cfuubpgcnv) = gdvyhnltfz pxmrgsvqyu (hczmcmalnk, kcnggfviaw - dqpyrbgzrh) View more | ||||||
Phase 3 | 222 | (Dexamethasone) | zjiadjduqk(ujjtagfprp) = dtlujwjchr gczqxhxqcz (nppztwieoy, qsvyptjpxv - ltsuepomkt) View more | - | 05 Sep 2024 | ||
(Placebo) | zjiadjduqk(ujjtagfprp) = vjmpnlknrn gczqxhxqcz (nppztwieoy, nrfmnxqtoi - ozvpdaccnm) View more | ||||||
Phase 3 | 49 | Placebo+Ibuprofen (Ibuprofen and Placebo) | xytqrmxazp(kcruxjkjzw) = lyqnqznmaw pilabqgfby (bcsaogesrp, 2.3) View more | - | 04 Sep 2024 | ||
(Ibuprofen and Acetaminophen) | xytqrmxazp(kcruxjkjzw) = pppsnvibry pilabqgfby (bcsaogesrp, 2.4) View more | ||||||
Phase 1/2 | 73 | (Opioid Pain Control) | udnsrofsor(cfoeyahnvp) = vxssbuxmdt qirxytftxo (tlbaatgyih, ilpaakxcea - qoakwpjugs) View more | - | 16 Aug 2024 | ||
(Non-opioid Pain Control) | udnsrofsor(cfoeyahnvp) = mjgtpvewbk qirxytftxo (tlbaatgyih, icgohggzqz - upaxxspzcy) View more |